Société
L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
SideROS est une société de biotechnologies développant des nouvelles entités chimiques ciblant le métabolisme du fer dans les cellules cancéreuses persistantes, afin de prévenir les récidives et métastases dans les cancers à mauvais pronostic
Paris, Île-de-France, France
Envoyer un message
Français
Français
SideROS is a preclinical stage biotech focused on iron interfering drug candidates development for patients at high-risk of relapse and metastasis. Preclinical evidences have been obtained in several indications such as breast cancer, DLBCL, acute myeloid leukemia, glioblastoma and colorectal cancer. Of interest, we have developed a biomarker, an iron score, combining the expression of genes linked to iron metabolism, which can identify patients at risk of relapses. That iron...
SideROS is a preclinical stage biotech focused on iron interfering drug candidates development for patients at high-risk of relapse and metastasis. Preclinical evidences have been obtained in several indications such as breast cancer, DLBCL, acute myeloid leukemia, glioblastoma and colorectal cancer. Of interest, we have developed a biomarker, an iron score, combining the expression of genes linked to iron metabolism, which can identify patients at risk of relapses. That iron score could be use to select patients who can benefit of our targeted therapy.